back to overview


Christoph Kausch selected by Real Deals as most influential for 2022

September 12, 2022 + Jessica Di Palo
2 Min read

Real Deals

Real Deals has compiled a list of the most influential individuals, firms and movements that have defined, innovated and transformed private equity over the last twelve months.

We are happy to share the news that Dr. Christoph Kausch, our Managing Partner at MTIP, made the list for Real Deals most influential for 2022. Real Deals publishes the most important European private equity news, alongside deep analysis and comprehensive deal coverage.

MTIP marks its place on this year’s list for being one of the first investors active in the healthtech space. Founding member of the Swiss-based growth equity healthtech investor, Dr. Christoph Kausch, has been instrumental in tailoring the firm’s investment thesis, backing digital health and digitally connected medical device companies. MTIP also takes an active role in ESG, with its second fund achieving “dark green” status as an Article 9 fund within SFDR. The practicalities of achieving Article 9 status have really come to light in 2022, with many of the latest PE fundraisings only able to get as high as Article 8. The status was achieved for MTIP’s contribution to tackling “inequality in access to quality healthcare for disadvantaged communities”. The GP also has a significant focus on social responsibility.

“Our mission at MTIP is to build the healthtech leaders of tomorrow,” said Dr. Christoph Kausch, Managing Partner at MTIP. “The trust our investors have put in us is a great endorsement of our strategy that’s built on our sector focus and proven approach to value creation. Being listed as one of Real Deals most influential individuals of 2022 is a phenomenal recognition for the achievements we secured in the last 12 months.”

About MTIP

MTIP is a leading Swiss-based growth equity firm investing in European healthtech companies. We leverage our deep sector expertise to help the founders scale up successful and sustainable digital health businesses. At MTIP, we are driven by the mission to empower healthtech innovation with the potential to impact and improve millions of lives.

Share the Article


Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022


MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment


MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium


Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development


The psychology of decision making

What makes a good investor?


Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage


MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!


Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!


MTIP invests in Mediktor

New investment in Mediktor


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

blog news

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II


How to pitch to a healthtech Investor

Blog Pitching


MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health


MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020


4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour


MTIP invests in Trialbee

New investment in Trialbee


TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round


The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April